Skip to content


NovoPath is a key component of Diagnostics and Therapeutics North East (DxNE/TxNE) which was established to bring together and present a unique seamless infrastructure to life science organisations to support innovation, development and evaluation of new therapeutics and diagnostics for the NHS. DxNE/TxNE offers an unrivalled network from discovery science to clinical adoption, evaluation and horizon scanning.


It is also an important part of the Research and Innovation strand of the recently established Newcastle Health Innovation Partners, Academic Health Science Centre (AHSC) which involves Newcastle University, NuTH and NTW NHS Trusts, Newcastle City Council and the North East and North Cumbria AHSN.